Category overview
What this section covers
Build a practical foundation for understanding cardiovascular risk, prevention conversations, and long-term heart care.
Explore all evergreen Blogs All health topics
Article category
Heart health articles and research
Clear guides to cardiovascular wellness, blood pressure, heart rhythm, movement, and informed conversations with your care team.
What readers can learn
Understand common heart-health risk factors
Prepare questions about screening and prevention
Connect movement, sleep, nutrition, and ageing
Related Blogs and guides
Build your understanding
Source guideHeart Health
Maintaining cardiovascular well-being involves understanding risk factors like high blood pressure, cholesterol, and family history. This educational guide explores evidence-based lifestyle adjustments and preventive measures to support long-term heart function, emphasizing the importance of regular medical consultations.
Open guide
Source guideHealthy Ageing
Healthy ageing focuses on maintaining physical, mental, and social well-being throughout life. It involves adopting positive lifestyle habits early on and managing health conditions to ensure independence, functional ability, and a good quality of life in older age.
Open guide
Source guideNutrition
Discover essential nutrition principles for better health. Learn how balanced diets, micronutrients, and healthy eating habits support well-being across life stages, with insights from WHO, CDC, and the ICMR Dietary Guidelines for Indians.
Open guideLatest Articles
Published coverage in Heart Health
Heart Health Sources listed
FDA Cardiovascular Machine-Learning Software Rule: What Class II Controls Mean
FDA’s 11 September final order codified class II special controls for software that suggests the likelihood of one cardiovascular condition, while the underlying De Novo classification dates to 2023 and the output is not diagnostic quality.
Heart Health Sources listed
Pelacarsen Lowers Lp(a) but Misses Phase 3 Cardiovascular Endpoint
Topline Lp(a)HORIZON results say pelacarsen lowered lipoprotein(a) but did not reduce the study's cardiovascular endpoint in the overall population.